RAS pathway mutations in Juvenile myelomonocytic leukemia

被引:7
作者
Emanuel, Peter D. [1 ]
机构
[1] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72202 USA
关键词
Juvenile myelomonocytic leukemia; RAS pathway; mutation;
D O I
10.1159/000140632
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Juvenile myelomonocytic leukemia (JMML) is a rare blood cell malignancy occurring in very young children. Yet, just as has been proven in other rare diseases, the study of JMML has provided us great insights into aberrant and dysregulated signal transduction through the Ras pathway, with the ultimate development of malignancy. Further, JMML investigations have also revealed to us much about the genetic predisposition to cancer. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码:207 / 211
页数:5
相关论文
共 25 条
[1]   Nf1 and Gmcsf interact in myeloid leukemogenesis [J].
Birnbaum, RA ;
O'Marcaigh, A ;
Wardak, Z ;
Zhang, YY ;
Dranoff, G ;
Jacks, T ;
Clapp, DW ;
Shannon, KM .
MOLECULAR CELL, 2000, 5 (01) :189-195
[2]   PROTEINS REGULATING RAS AND ITS RELATIVES [J].
BOGUSKI, MS ;
MCCORMICK, F .
NATURE, 1993, 366 (6456) :643-654
[3]   Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells [J].
Bollag, G ;
Clapp, DW ;
Shih, S ;
Adler, F ;
Zhang, YY ;
Thompson, P ;
Lange, BJ ;
Freedman, MH ;
McCormick, F ;
Jacks, T ;
Shannon, K .
NATURE GENETICS, 1996, 12 (02) :144-148
[4]  
BOS JL, 1989, CANCER RES, V49, P4682
[5]  
BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0
[6]   THE GTPASE SUPERFAMILY - A CONSERVED SWITCH FOR DIVERSE CELL FUNCTIONS [J].
BOURNE, HR ;
SANDERS, DA ;
MCCORMICK, F .
NATURE, 1990, 348 (6297) :125-132
[7]   Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder [J].
Braun, BS ;
Tuveson, DA ;
Kong, N ;
Le, DT ;
Kogan, SC ;
Rozmus, J ;
Le Beau, MM ;
Jacks, TE ;
Shannon, KM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :597-602
[8]   CLONALITY IN JUVENILE CHRONIC MYELOGENOUS LEUKEMIA [J].
BUSQUE, L ;
GILLILAND, DG ;
PRCHAL, JT ;
SIEFF, CA ;
WEINSTEIN, HJ ;
SOKOL, JM ;
BELICKOVA, M ;
WAYNE, AS ;
ZUCKERMAN, KS ;
SOKOL, L ;
CASTLEBERRY, RP ;
EMANUEL, PD .
BLOOD, 1995, 85 (01) :21-30
[9]   Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease [J].
Chan, IT ;
Kutok, JL ;
Williams, IR ;
Cohen, S ;
Kelly, L ;
Shigematsu, H ;
Johnson, L ;
Akashi, K ;
Tuveson, DA ;
Jacks, T ;
Gilliland, DG .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (04) :528-538
[10]  
EMANUEL PD, 1991, BLOOD, V77, P925